ILK and breast carcinoma: Consistent with ILK exerting control over cell differentiation programming, ILK perturbation in the breast cancer cell line MDA-MB-231 resulted in impaired cell migration and reduced expression of mesenchymal markers such as α-smooth muscle actin.